The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-Cell Leukaemia

David J. Flavell, Suzanne E. Holmes, Sarah L Warnes, Sopsamorn U. Flavell

Open source

DOI
10.3390/biomedicines7010013
Published
2019-02-16
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines7010013,
  title = {The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-Cell Leukaemia},
  author = {David J. Flavell and Suzanne E. Holmes and Sarah L Warnes and Sopsamorn U. Flavell},
  year = {2019},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines7010013},
  url = {https://doi.org/10.3390/biomedicines7010013}
}

RIS

TY  - JOUR
TI  - The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-Cell Leukaemia
AU  - David J. Flavell
AU  - Suzanne E. Holmes
AU  - Sarah L Warnes
AU  - Sopsamorn U. Flavell
PY  - 2019
JO  - Biomedicines
DO  - 10.3390/biomedicines7010013
UR  - https://doi.org/10.3390/biomedicines7010013
ER  - 

APA

Flavell, D. J., Holmes, S. E., Warnes, S. L., & Flavell, S. U. (2019). The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-Cell Leukaemia. Biomedicines. https://doi.org/10.3390/biomedicines7010013

Source records